Patents by Inventor Paul Willis

Paul Willis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Arrangement of seat units in a vehicle cabin
    Patent number: 10301027
    Abstract: Described are commercial aircraft cabin arrangement comprising a plurality of seat units (14), each seat unit including a primary seat (16) and a secondary seat (18) arranged facing one another. The primary seat (16) and the secondary seat (18) are configured to combine into a single bed position for the seat unit. The plurality of seat units (14) are arranged in two columns separated by a wide central aisle (72).
    Type: Grant
    Filed: October 24, 2014
    Date of Patent: May 28, 2019
    Assignee: Safran Seats GB Limited
    Inventors: Alison Gill, Rachel Lisa West, Claude Martin, Paul Willis
  • ARRANGEMENT OF SEAT UNITS IN A VEHICLE CABIN
    Publication number: 20160257408
    Abstract: Described are commercial aircraft cabin arrangement comprising a plurality of seat units (14), each seat unit including a primary seat (16) and a secondary seat (18) arranged facing one another. The primary seat (16) and the secondary seat (18) are configured to combine into a single bed position for the seat unit. The plurality of seat units (14) are arranged in two columns separated by a wide central aisle (72).
    Type: Application
    Filed: October 24, 2014
    Publication date: September 8, 2016
    Inventors: Alison Gill, Rachel Lisa West, Claude Martin, Paul Willis
  • TRISUBSTITUTED TRIAZOLOPYRIMIDINES FOR USE IN PLATELET AGGREGATION INHIBITION
    Publication number: 20150152111
    Abstract: The invention provides new triazolo[4,5-d]pyrimidine compounds, their use as medicaments, compositions containing them and processes for their preparation.
    Type: Application
    Filed: June 20, 2014
    Publication date: June 4, 2015
    Applicant: AstraZeneca UK Limited
    Inventors: David Hardern, Anthony Ingall, Brian Springthorpe, Paul Willis, Simon Guile
  • TRISUBSTITUTED TRIAZOLOPYRIMIDINES FOR USE IN PLATELET AGGREGATION INHIBITON
    Publication number: 20140296258
    Abstract: The invention provides new triazolo[4,5-d]pyrimidine compounds, their use as medicaments, compositions containing them and processes for their preparation.
    Type: Application
    Filed: October 31, 2013
    Publication date: October 2, 2014
    Applicant: AstraZeneca UK Limited
    Inventors: David Hardern, Anthony Ingall, Brian Springthorpe, Paul Willis, Simon Guile
  • TRISUBSTITUTED TRIAZOLOPYRIMIDINES FOR USE IN PLATELET AGGREGATION INHIBITION
    Publication number: 20130072503
    Abstract: The invention provides new triazolo[4,5-d]pyrimidine compounds, their use as medicaments, compositions containing them and processes for their preparation.
    Type: Application
    Filed: March 19, 2012
    Publication date: March 21, 2013
    Applicant: AstraZeneca
    Inventors: David Hardern, Anthony Ingall, Brian Springthorpe, Paul Willis, Simon Guile
  • Novel compounds
    Publication number: 20120165348
    Abstract: The invention provides new triazolo[4,5-d]pyrimidine compounds, their use as medicaments, compositions containing them and processes for their preparation.
    Type: Application
    Filed: July 21, 2011
    Publication date: June 28, 2012
    Applicant: AstraZeneca AB
    Inventors: David Hardern, Anthony Ingall, Brian Springthorpe, Paul Willis, Simon Guile
  • Compounds and their uses 707
    Patent number: 8012979
    Abstract: The present invention relates to isoquinolinone derivatives of formula (I): wherein R1, R2, R3, R4, R5, R6 and R7 are as herein defined; processes for their preparation, pharmaceutical compositions containing them and their use in therapy.
    Type: Grant
    Filed: April 4, 2008
    Date of Patent: September 6, 2011
    Assignee: AstraZeneca AB
    Inventors: Matthew Hallam, Barrie Martin, Piotr Raubo, Bryan Roberts, Stephen St-Gallay, Paul Willis
  • ISOQUINOLINE DERIVATIVES AND THEIR USE AS INHIBITORS OF CYTOKINE MEDIATED DISEASES
    Publication number: 20100234355
    Abstract: The invention concerns a compound of formula (I) or pharmaceutically-acceptable salts thereof wherein R1, R2, R3, R4, R5 and m are as defined in the specification, processes for their preparation, pharmaceutical compositions containing them and their use in the treatment of diseases or medical conditions mediated by cytokines.
    Type: Application
    Filed: June 18, 2007
    Publication date: September 16, 2010
    Inventors: Barrie Martin, Paul Willis
  • Trisubstituted triazolopyrimidines for use in platelet aggregation inhibition
    Publication number: 20100069408
    Abstract: The invention provides new triazolo[4,5-d]pyrimidine compounds, their use as medicaments, compositions containing them and processes for their preparation.
    Type: Application
    Filed: November 18, 2009
    Publication date: March 18, 2010
    Applicant: AstraZeneca AB
    Inventors: David Hardern, Anthony Ingall, Brian Springthorpe, Paul Willis, Simon Guile
  • Adamantane derivatives
    Publication number: 20090176853
    Abstract: The invention provides adamantane derivatives of formula (I), a process for their preparation, pharmaceutical compositions containing them, a process for preparing the pharmaceutical compositions, and their use in therapy. In formula (I) D represents CH2 or CH2CH2, E represents C(O)NH or NHC(O) and R3 represents a group of formula (I).
    Type: Application
    Filed: December 4, 2008
    Publication date: July 9, 2009
    Inventors: Lilian Alcaraz, Moya Caffrey, Mark Furber, Timothy Luker, Michael Mortimore, Austen Pimm, Philip Thorne, Paul Willis
  • P2X7 Receptor Antagonists and Their Use
    Publication number: 20090143354
    Abstract: The invention provides compounds of formula (IA), processes for their preparation, pharmaceutical compositions containing them, and their use in therapy.
    Type: Application
    Filed: May 2, 2008
    Publication date: June 4, 2009
    Inventors: Richard Evans, Christine Eyssade, Rhonan Ford, Barrie Martin, Toby Thompson, Paul Willis
  • COMPOUNDS AND THEIR USES 707
    Publication number: 20090023746
    Abstract: The present invention relates to isoquinolinone derivatives of formula (I): wherein R1, R2, R3, R4, R5, R6 and R7 are as herein defined; processes for their preparation, pharmaceutical compositions containing them and their use in therapy.
    Type: Application
    Filed: April 4, 2008
    Publication date: January 22, 2009
    Applicant: AstraZeneca AB
    Inventors: Matthew Hallam, Barrie Martin, Piotr Raubo, Bryan Roberts, Stephen St-Gallay, Paul Willis
  • Trisubstituted triazolopyrimidines for use in platelet aggregation inhibition
    Publication number: 20080214812
    Abstract: The invention provides new triazolo[4,5-d]pyrimidine compounds, their use as medicaments, compositions containing them and processes for their preparation.
    Type: Application
    Filed: May 8, 2008
    Publication date: September 4, 2008
    Applicant: AstraZeneca AB
    Inventors: David Hardern, Anthony Ingall, Brian Springthorpe, Paul Willis, Simon Guile
  • Novel compounds 329
    Publication number: 20080207596
    Abstract: The invention concerns a compound of formula (I) or pharmaceutically-acceptable salts thereof wherein R1, R2, R3, R4, R5 and m are as defined in the specification, processes for their preparation, pharmaceutical compositions containing them and their use in the treatment of diseases or medical conditions mediated by cytokines.
    Type: Application
    Filed: June 19, 2007
    Publication date: August 28, 2008
    Inventors: Barrie Martin, Paul Willis
  • P2Xreceptor antagonists and their use
    Patent number: 7408065
    Abstract: The invention provides compounds of formula (IA), processes for their preparation, pharmaceutical compositions containing them, and their use in therapy.
    Type: Grant
    Filed: June 1, 2004
    Date of Patent: August 5, 2008
    Assignee: AstraZeneca AB
    Inventors: Richard Evans, Christine Eyssade, Rhonan Ford, Barrie Martin, Toby Thompson, Paul Willis
  • Novel Compounds
    Publication number: 20080182874
    Abstract: The invention provides compounds of formula (I), or a pharmaceutically acceptable salt or an in vivo hydrolysable ester thereof, in which A, n, p, q, R1, R2, R3 and R4 are as defined in the specification; a process for their preparation; pharmaceutical compositions containing them; and their use in therapy.
    Type: Application
    Filed: November 28, 2005
    Publication date: July 31, 2008
    Applicant: ASTRAZENECA AB
    Inventors: Richard Evans, Rhonan Ford, Toby Thompson, Paul Willis
  • Adamantyl Derivates as P2x7 Receptor Antagonists
    Publication number: 20080153850
    Abstract: The invention provides compounds of formula (I) pharmaceutically acceptable salt or solvate thereof, in which R1, A1, m and A are as defined in the specification; a process for their preparation; pharmaceutical compositions containing them; and their use in therapy.
    Type: Application
    Filed: August 29, 2005
    Publication date: June 26, 2008
    Applicant: AstraZeneca AB
    Inventors: Rhonan Ford, Barrie Martin, Toby Thompson, Nicholas Tomkinson, Paul Willis
  • Novel Biaromatic Compounds, Inhibitors of the P2X7-Receptor
    Publication number: 20080146612
    Abstract: The invention provides compounds of formula (I), or a pharmaceutically acceptable salt thereof, wherein Ar1 represents a group (II), (III), (IV) or (V), and A, Ar2, n, R1, R2, R3, R4 and R5 are as defined in the specification; a process for their preparation; pharmaceutical compositions containing them; and their use in therapy.
    Type: Application
    Filed: January 25, 2006
    Publication date: June 19, 2008
    Applicant: ASTRAZENECA AB
    Inventors: Toby Thompson, Paul Willis
  • Adamantane derivatives
    Publication number: 20080139636
    Abstract: The invention provides adamantane derivatives of formula (I), a process for their preparation, pharmaceutical compositions containing them, a process for preparing the pharmaceutical compositions, and their use in therapy. In formula (I) D represents CH2 or CH2CH2, E represents C(O)NH or NHC(O) and R3 represents a group of formula (I).
    Type: Application
    Filed: June 20, 2007
    Publication date: June 12, 2008
    Inventors: Lilian Alcaraz, Moya Caffrey, Mark Furber, Timothy Luker, Michael Mortimore, Austen Pimm, Philip Thorne, Paul Willis
  • Triazolo(4,5-D)pyrimidine compounds
    Patent number: RE46276
    Abstract: Triazolo[4,5-d]pyrimidine compounds, their use as medicaments, compositions containing them and processes for their preparation. The compounds of the invention have the formula (I) as follows: wherein R, X and R1 through R3 are as defined in the specification.
    Type: Grant
    Filed: December 21, 2015
    Date of Patent: January 17, 2017
    Assignee: AstraZeneca UK Limited
    Inventors: David Hardem, Anthony Ingall, Brian Springthorpe, Paul Willis, Simon Guile